Cargando…
Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383529/ https://www.ncbi.nlm.nih.gov/pubmed/32303564 http://dx.doi.org/10.1128/JCM.00760-20 |
| _version_ | 1783563435850596352 |
|---|---|
| author | Rhoads, Daniel D. Cherian, Sree S. Roman, Katharine Stempak, Lisa M. Schmotzer, Christine L. Sadri, Navid |
| author_facet | Rhoads, Daniel D. Cherian, Sree S. Roman, Katharine Stempak, Lisa M. Schmotzer, Christine L. Sadri, Navid |
| author_sort | Rhoads, Daniel D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7383529 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Society for Microbiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73835292020-07-31 Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19 Rhoads, Daniel D. Cherian, Sree S. Roman, Katharine Stempak, Lisa M. Schmotzer, Christine L. Sadri, Navid J Clin Microbiol Letter to the Editor American Society for Microbiology 2020-07-23 /pmc/articles/PMC7383529/ /pubmed/32303564 http://dx.doi.org/10.1128/JCM.00760-20 Text en Copyright © 2020 Rhoads et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Rhoads, Daniel D. Cherian, Sree S. Roman, Katharine Stempak, Lisa M. Schmotzer, Christine L. Sadri, Navid Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19 |
| title | Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19 |
| title_full | Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19 |
| title_fullStr | Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19 |
| title_full_unstemmed | Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19 |
| title_short | Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19 |
| title_sort | comparison of abbott id now, diasorin simplexa, and cdc fda emergency use authorization methods for the detection of sars-cov-2 from nasopharyngeal and nasal swabs from individuals diagnosed with covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383529/ https://www.ncbi.nlm.nih.gov/pubmed/32303564 http://dx.doi.org/10.1128/JCM.00760-20 |
| work_keys_str_mv | AT rhoadsdanield comparisonofabbottidnowdiasorinsimplexaandcdcfdaemergencyuseauthorizationmethodsforthedetectionofsarscov2fromnasopharyngealandnasalswabsfromindividualsdiagnosedwithcovid19 AT cheriansrees comparisonofabbottidnowdiasorinsimplexaandcdcfdaemergencyuseauthorizationmethodsforthedetectionofsarscov2fromnasopharyngealandnasalswabsfromindividualsdiagnosedwithcovid19 AT romankatharine comparisonofabbottidnowdiasorinsimplexaandcdcfdaemergencyuseauthorizationmethodsforthedetectionofsarscov2fromnasopharyngealandnasalswabsfromindividualsdiagnosedwithcovid19 AT stempaklisam comparisonofabbottidnowdiasorinsimplexaandcdcfdaemergencyuseauthorizationmethodsforthedetectionofsarscov2fromnasopharyngealandnasalswabsfromindividualsdiagnosedwithcovid19 AT schmotzerchristinel comparisonofabbottidnowdiasorinsimplexaandcdcfdaemergencyuseauthorizationmethodsforthedetectionofsarscov2fromnasopharyngealandnasalswabsfromindividualsdiagnosedwithcovid19 AT sadrinavid comparisonofabbottidnowdiasorinsimplexaandcdcfdaemergencyuseauthorizationmethodsforthedetectionofsarscov2fromnasopharyngealandnasalswabsfromindividualsdiagnosedwithcovid19 |